Format

Send to

Choose Destination
Neuro Oncol. 2004 Jan;6(1):63-4.

Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy.

Author information

1
Hermelin Brain Tumor Center, Department of Neurosurgery, Henry Ford Hospital, Detroit, MI 48202, USA. lrogers@neuro.hfh.edu

Abstract

We report a durable (12-month) response to capecitabine monotherapy, shown clinically, by MRI, and by cerebrospinal fluid analysis, in a patient with leptomeningeal metastasis from breast cancer.

PMID:
14769142
PMCID:
PMC1871963
DOI:
10.1215/S1152851703000334
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center